Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

memo - Magazine of European Medical Oncology

Issue 3/2023

Content (17 Articles)

Mantle Cell Lymphoma editorial

American Society of Hematology meeting update

Dominik Wolf

Epstein-Barr Virus editorial

Head and neck cancer revisited

Thorsten Füreder

Pediatrics editorial

Long-term survival and follow-up care after cancer in Austria

Alexandra Böhm

Diffuse Large B-Cell Lymphoma short review

Aggressive B cell lymphomas—highlights from ASH 2022

Michael Panny

Open Access Myelodysplastic Syndrome short review

FlASHback—personal highlights regarding myelodysplastic syndrome from the 2022 ASH meeting

Verena Petzer, Dominik Wolf

Acute Myeloid Leukemia review

ASH 2022—new developments in acute myeloid leukemia

Michael Pfeilstöcker

Open Access Multiple Myeloma short review

ASH highlights 2022—multiple myeloma

Lina Z. Rüsing, Hermine Agis, Maria Krauth

Open Access Epstein-Barr Virus short review

Nasopharyngeal carcinoma

Thorsten Fuereder

Open Access Radiotherapy short review

New developments in radiation oncology for head and neck cancers

Christoph Resl, Petra Georg, Carmen Döller

Open Access Cetuximab short review

Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma

Florian Kocher, Andreas Seeber

Cancer Fatigue short review

Late complications after oncological therapy

Marco Hassler

Open Access short review

How the long-term follow-up is organized in young adult survivors of childhood cancer

Edit Bardi, Leo Kager, Wolfgang Holter

Adenovirus short review

Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer

Dominik A. Barth, Martin Pichler

Open Access Lung Cancer short review

Lipid nanoparticles in the treatment of lung cancer—hype or hope?

Anna Mair, Fabienne Nocera, Dominik Wolf, Andreas Pircher

Open Access Trastuzumab Deruxtecan leading article

Emerging molecular drugs for the treatment of gastroesophageal tumors

Aysegül Ilhan-Mutlu

Open Access Malnutrition original report

Assessment of nutritional status using objective and subjective methods in Greek patients with cancer

Konstantina Vamvakari, Iliana Evangelou, Ioanna Panagiota Kalafati, Michail Kipouros, Rena I. Kosti, Arezina N. Kasti, Odysseas Androutsos

Hemophagocytic Lymphohistiocytosis case report

Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin

Kaoutar Meliani, Noufissa Alami Dribi, Widad Rhandour, Afaf Amarti Riffi, Zineb Khammar, Rhyzlane Berrady

Aug 23
Issue: Special Issue 7/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd-6th June 2023, European Hematology Association (EHA) 2023 Congress (hybrid), 8th-11th June 2023, and the 17th International Conference on Malignant Lymphoma (ICML) 2023 Congress (hybrid), 13th-17th June 2023
Dec 23
Issue: 4/2023

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits